Literature DB >> 10204689

Specific changes in beta2-adrenoceptor trafficking kinetics and intracellular sorting during downregulation.

R H Moore1, H S Hall, J L Rosenfeld, W Dai, B J Knoll.   

Abstract

Agonist-activated beta2-adrenoceptors rapidly internalize and then recycle to the cell surface, however chronic agonist eventually causes receptor downregulation. To characterize beta2-adrenoceptor trafficking kinetics and intracellular sorting during downregulation, human embryonic kidney cells expressing epitope-tagged receptors were examined by radioligand binding with (+/-)-[3H]4-(3-tertiarybutylamino-2-hydroxypropoxy)-benzimidazole- 2-on hydrochloride ([3H]CGP12177) and immunofluorescence microscopy. The first-order receptor recycling rate constant declined after 18 h of agonist compared with 15 min (0.05 min(-1) vs. 0.12 min(-1)), thus increasing the intracellular transit time (20.0 min vs. 8.3 min). There was also a reduction in the rate of receptor endocytosis and a decline in the total number of receptors. Although the intracellular receptor fraction did not increase between 15 min and 18 h of agonist, some receptors moved irreversibly into a protease-containing compartment while retaining radioligand binding activity. Our results indicate that beta2-adrenoceptor downregulation is associated principally with an increased intracellular transit time during recycling. This could promote the diversion of receptors into protease-containing compartments, where there is an irreversible commitment to downregulation prior to loss of radioligand binding activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10204689     DOI: 10.1016/s0014-2999(99)00055-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulation.

Authors:  Xiaofeng Jiang; Hui Pan; Joseph F Nabhan; Ramaswamy Krishnan; Cynthia Koziol-White; Reynold A Panettieri; Quan Lu
Journal:  FASEB J       Date:  2012-01-25       Impact factor: 5.191

2.  Differential phosphorylation and dephosphorylation of beta2-adrenoceptor sites Ser262 and Ser355,356.

Authors:  Varsha Iyer; Tuan M Tran; Estrella Foster; Wenping Dai; Richard B Clark; Brian J Knoll
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  Effects of the β-agonist, isoprenaline, on the down-regulation, functional responsiveness and trafficking of β2-adrenergic receptors with N-terminal polymorphisms.

Authors:  Yulia Koryakina; Stacie M Jones; Lawrence E Cornett; Kathryn Seely; Lisa Brents; Paul L Prather; Alexander Kofman; Richard C Kurten
Journal:  Cell Biol Int       Date:  2012       Impact factor: 3.612

4.  Mutating the dileucine motif of the human beta(2)-adrenoceptor reduces the high initial rate of receptor phosphorylation by GRK without affecting postendocytic sorting.

Authors:  Hibah O Awwad; Ellen E Millman; Estrella Alpizar-Foster; Robert H Moore; Brian J Knoll
Journal:  Eur J Pharmacol       Date:  2010-03-01       Impact factor: 4.432

5.  Endosome sorting of beta 2-adrenoceptors is GRK5 independent.

Authors:  Ellen E Millman; Jennifer L Rosenfeld; David J Vaughan; Jacqueline Nguyen; WenPing Dai; Estrella Alpizar-Foster; Richard B Clark; Brian J Knoll; Robert H Moore
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.